Related Experiment Video
Updated: Aug 5, 2026
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
The role of cytokines in unstable angina
L M Biasucci1, G Liuzzo, C Colizzi
1Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy.
Insights
Inflammation, driven by cytokines like IL-6, is key in unstable angina. Targeting this inflammation may offer new therapeutic strategies for acute coronary syndromes.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biochemistry
Background:
- Inflammation is increasingly recognized in unstable angina pathogenesis.
- Acute phase proteins like C-reactive protein (CRP) and fibrinogen indicate inflammation's role.
- Pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6), likely mediate this inflammatory process.
Purpose of the Study:
- To explore the involvement of pro-inflammatory cytokines in unstable angina.
- To understand the mechanisms by which cytokines contribute to acute coronary syndromes.
- To evaluate the potential of anti-inflammatory therapy for unstable angina.
Main Methods:
- Review of existing evidence on inflammation and acute phase proteins in unstable angina.
- Analysis of studies reporting cytokine levels in patients with acute coronary syndromes.
- Discussion of potential cytokine-mediated pathways including endothelial dysfunction, plaque instability, and immune cell activation.
Main Results:
- Elevated levels of IL-1 and IL-6 are observed in patients with acute coronary syndromes.
- Cytokines may promote coagulation, endothelial dysfunction, and plaque rupture.
- Cytokines can activate immune cells like neutrophils and mast cells.
Conclusions:
- Cytokines play multifaceted roles in the pathophysiology of unstable angina.
- The precise trigger and mechanisms of cytokine activation in this condition remain unclear.
- Targeted anti-inflammatory therapies represent a promising future treatment avenue for unstable angina.
Abstract:
A growing body of evidence suggests that inflammation plays a major role in the pathogenesis of unstable angina; this evidence is mainly derived from the prognostic role of the acute phase reaction proteins, such as C-reactive protein (CRP) and fibrinogen. Since the production of acute phase protein is under the control of the pro-inflammatory cytokines, it is probable that citokines, such as tumour-necrosis factor (TNF)-alpha, interleukin (IL)-1 and IL-6 are involved in the same process. Indeed, elevated levels of IL-1 and IL-6 have been found by our group and by others, in patients with acute coronary syndromes. Cytokines may have procoagulant effects, directly or via endothelial dysfunction, and may induce plaque vulnerability or rupture. They may also be responsible for the activation of other cells, as neutrophils or mast-cells. Although it is conceivable that activated lymphocytes, via interferon-gamma production, are responsible for macrophage activation and cytokine production in unstable angina, the trigger and the precise mechanism of this event are still unknown. The multiple roles of cytokines in unstable angina suggest that a targeted anti-inflammatory therapy might be a novel approach in the future for the treatment of this syndrome.
More Related Videos
Related Concept Videos
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Angina I: Introduction
01:27Angina II: Classification
01:26Angina IV: Management
01:20Angina V: Nursing Management